Immunotherapies
have evolved
Harnessing more of the immune system for better cancer outcomes
Latest News

Welcome to the oNKo family, Dr Imran House! @ImranHouse brings extensive experience in tumour immunology, CRISPR-based gene engineering and cellular therapies to continue his passion of inventing new ways to use the immune system to fight cancer. Read more https://tinyurl.com/5dcw3hce

Jai Rautela and Chacko Joseph @chaks86 will be representing oNKo-innate in San Diego, June 13-16 at BIO 2022. Find oNKo-innate in the partnering system and let's find ways to collaborate! #BIO2022 #LimitlessTogether

Load More...
 
Discover oNKo-innate
With our deep understanding of Natural Killer (NK) cells, we aim to be the first to master NK cell biology and therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.
Learn more
OUR APPROACH
Using powerful genomic approaches, we screen primary immune cells and cancer cells to understand their interaction within a tumor.
Learn more
lab1-webRes
o o
o
THE TEAM
We are driven by the challenge of engaging the immune system to fight cancer, and focused on delivering the first truly effective NK cell immunotherapies.
Find out who we are